Gender equity and environmental sustainability may seem like unrelated issues, but research shows that they are in fact closely intertwined. Women and other underserved groups are disproportionately impacted by the global climate crisis, but they are also uniquely positioned to lead the fight for sustainability.
If you have no idea what Web3 is or why it’s important, you are not alone. The term was coined by Ethereum’s co-founder, and it is actually quite vague. But, enthusiasts on the subject say Web3 is the future of the internet and there are two main ways to define it.
In theory, hybrid offers the best deal for both employer and employee. It combines pre-Covid-19 patterns of office-based working with remote days, in a working schedule that would allow both in-person collaboration and team building, as well as greater flexibility and the opportunity for focused work at home. It seemed a win-win for workers.
After a contract manufacturing snafu in December, supply of Novo Nordisk’s GLP-1 med for obesity appears to be back on track in the U.S.—mostly. Novo’s Wegovy manufacturing partner—which the Danish company previously confirmed to Fierce Pharma as Catalent—restarted production on the med in 2022’s second quarter. As a result, 1.7-mg and 2.4-mg doses of Wegovy are back on tap in the U.S. market, Novo said in a recent investor report.
Once the offer is settled, CSL expects to get its hands on more than 97% of Vifor shares. At the same time, CSL plans to have Vifor apply for the delisting of its shares post-close. CSL has also filed an action to cancel remaining publicly held Vifor shares to satisfy Swiss takeover rules.
